User:Mr. Ibrahem/Poractant alfa

Poractant alfa, sold under the brand name Curosurf among others, is a medication used to treat and prevent respiratory distress syndrome (RDS) in premature babies. It decreases the risk of death and pneumothoraces. It is given into the trachea.

Common side effects include slow heart rate, low blood pressure, and low oxygen. Other side effects may include blockage of the endotracheal tube. It is composed of pulmonary surfactant which is made up of phospholipids and surfactant proteins.

was approved for medical use in the United States in 1999. In the United States it costs about 1,000 USD for 3 mL as of 2021. It is made from pig lungs.